June 2018: The Draft Lower Limb Prostheses Policy Has Been Retired
The Inter Agency Workgroup which was formed to provide a consensus statement to inform Medicare coverage of lower limb prostheses has been published. As part of the consensus statement, the Inter Agency Workgroup recommended, and CMS concurred, that the draft LCD and Policy Article for Lower Limb Prostheses, that was initially released on July 16, 2015, should be removed from the DME MAC websites and that the current LCD and Policy Article should remain in force for the immediate future.
On June 21, 2018, the DME MACs released a joint publication announcing the retirement of both the draft LCD and Policy Article.
The announcement of the draft LCD and Policy Article may be viewed by clicking here.
December 2016: The Agency for Healthcare Research & Quality Solicits Public Comments
On December 1, 2016 the Agency for Healthcare Research and Quality (AHRQ) announced that it was soliciting public comment on the key questions that would be used in its previously announced systematic review of clinical literature relative to lower limb prostheses. Comments were to be submitted no later than 11:59 pm on December 20, 2016.
AOPA, with significant input from its Medical Advisory Board and its expert steering committee, as well as AOPA Board members, developed and submitted detailed comments that addressed both the systematic review in general as well as responses to the 8 key questions on which the AHRQ had requested comments. In addition to its own comments, AOPA actively contributed to comments developed and submitted by the O&P Alliance, and AOPA expressed in our submission to AHRQ that we also join in and support the comments of the O&P Alliance of which AOPA is a member. Many other organizations and individuals have also submitted comments on this very important topic.
October 2016: The Agency for Healthcare Research & Quality Begins Systematic Review for Lower Limb Prostheses
In October 2016, the Agency for Healthcare Research and Quality (AHRQ), the “government agency tasked with producing evidence to improve the quality of healthcare while working with partners to ensure that the evidence is understood and used” recently announced that it will be initiating a systematic review for lower limb prostheses. The systematic review will be performed through the Evidence Based Practice Center Program of the AHRQ and the stated purpose of the systematic review is “to examine the available clinical evidence that defines practices in the care of beneficiaries who require lower limb prostheses (LLP).”
While the announcement does not tie the systematic review to the work of the inter-agency taskforce assigned to review the delayed draft Local Coverage Determination (LCD) that was released by the DME MACs in the summer of 2015, it is clear that the initiation of the systematic review for lower limb prostheses is directly related to the work of this taskforce.
AOPA will be requesting a meeting with representatives of the AHRQ in order to discuss existing systematic reviews for lower limb prostheses that have recently been completed through AOPA funding as well as the previous and current cost effectiveness studies that have been developed by Dobson DaVanzo. In addition, AOPA will discuss the ongoing work of the RAND Corporation to determine the cost effectiveness of prosthetic intervention.
June 2016: Select Language Included in Appropriations Bill
In June 2016, as a result of the series of meetings during the Policy Forum involving Senator Kerrey and top members of the Senate and the Finance Committee, and particularly through AOPA Past President Tom Watson’s intercession with Senate Majority Leader McConnell, important language was inserted into the Committee report which has been prepared to explain the 2017 Senate Labor/HHS Appropriations Bill. This is an important directive to CMS, essentially that in light of reductions in Medicare prosthetic spend over 2012-2014, there seems no necessity for intervention to change the LCD, and instructing CMS to consult with clinicians, patients and prosthetist groups before releasing any new or revised version of the LCD.
The language included in the report is as follows:
“The Committee recognizes that Medicare payments for all prosthetics, and especially the newer advanced technologies, have declined over each of the years 2010-2014. The committee encourages CMS to consult broadly with clinicians, patient groups, and the prosthetics field regarding revisions to the draft Local Coverage Determination, prior to publishing an updated draft policy for public comment.”
April 2016: AOPA Press Conference & LCD Moratorium
On April 21, 2016, AOPA held a press conference call to discuss the impact that CMS’ proposed Lower Limb LCD is having in the private sector. Media participants heard from AOPA President Elect Michael Oros, CPO, FAAOP and two amputees who have been affected by the new policies. Listen to the audio from the call and the press release summarizing the call.
On April 25, Rep. Renee Ellmers (R-NC) and Rep. Jan Schakowsky (D-IL) introduced H.R. 5045, a bill that would establish a moratorium on any action on the LCD through Spring 2017 and remove the withdrawn LCD from the CMS and DME MAC websites and establishing that, contrary to some legal interpretations at HHS, CMS indeed can, and is obliged to manage and instruct its contractors, including the DME MACs, what to do across topics including LCD issues.
The LCD’s Influence on the Private Sector
United Health Care (UHC) Denies Medical Necessity of Vacuum Pumps: AOPA’s Strategy Moving Forward
In this new policy, which seems to be a result of the LCD Proposal, United Health Care deems vacuum pumps for residual limb volume management “…unproven and not medically necessary” as of October 1, 2015. Read the policy here.
AOPA is pursuing a two part strategy: (a) AOPA partnered with a congressional representative in UHC’s state, who contacted UHC requesting that they set up a high level meeting with AOPA reps; and (b) AOPA has joined in a letter of objection to the policy from the O&P Alliance, together with the Amputee Coalition, challenging the assertion that there is no scientific evidence to support this treatment, and seeking a meeting with UHC’s Medical Director. We believe the results can be additive and symbiotic, not divisive, in bringing attention to the problem from multiple directions. Read UHC’s disappointing response and then the O&P Alliance’s rebuttal.
Cigna has taken the same action. See the letter from the O&P Alliance and the Amputee Coalition to Cigna.
We promise to continue to keep you posted on the UHC issues, but we have also received an early indication about another mischievous outgrowth of the commercial sector jumping on the draft LCD as an opportunity for cutbacks–this time from one of the state BCBS plans. We are waiting to see documentation, but if this proves correct, we will again communicate with the insurer AND communicate to CMS (as we did when the UHC policy first arose) underscoring yet again the need for a quick decision to rescind the draft LCD. Read this news article about the issue.
AOPA’s Actions after the LCD was Proposed
WITHIN A MATTER OF DAYS of the July 16, 2015 draft policy issued by the DME MACs, AOPA mobilized its members, allies, and advisers to work on multiple strategies to have this ill-conceived policy rescinded. The O&P Community, the amputee community and the leadership of the groups that represent them, quickly banded together in a coordinated effort to make sure our O&P voices were heard. AOPA created an action plan to guide our overall strategy.
On November 2, 2015, the White House issued a statement that the proposal would not be finalized. (Read the initial petition here.) CMS would be convening a workgroup of clinicians, researchers, and policy specialists. The immediate concern is that this is NOT a rescission of the Draft LCD. Some might see this as following a too frequent government step of “kicking the can down the road.” AOPA’s leadership and regulatory specialists will review ALL government and contractor communications as they arise, and provide a further analysis once that in-depth review is complete. Read AOPA’s full statement on the White House announcement. Read the CMS statement, and the DMEMAC statements – Jurisdiction A, Jurisdiction B, Jurisdiction C, Jurisdiction D.
Below are the most important actions AOPA took on your behalf to fight this devastating proposed policy:
For the first time ever, AOPA organized a patient rally of more than 150 amputees at the U.S. Department of Health and Human Services (HHS) headquarters.
AOPA arranged for buses from DME MAC hearing to the rally in front of the HHS building. Amputees and non-amputees joined together and made sure their voices were heard for almost 3 hours as they marched, rallied, gave speeches, and literally stood on a soap box to deliver the message to CMS that artificial limbs are not a luxury.
AOPA submitted 43 pages of comments on the draft policy. AOPA provided prewritten comments on AOPAVotes.org and mailed patient postcards to members. This generated over 5,070 comments from patients, practitioners and other O&P professionals, which have been included in the official record for the LCD rule making.
AOPA arranged for five speakers at the August 26th DME MAC public meeting in Linthicum, including AOPA President Charlie Dankmeyer, CPO, AOPA Past President Tom Watson, CP, AOPA President-elect Jim Campbell, PhD, CO, AOPA Executive Director Tom Fise and Boston Marathon Amputee Adrianne Haslet.
Communicating with HHS on Policy
On August 26th, at the end of the HHS rally, responding to an August 25th request from AOPA to meet with HHS Secretary Burwell, representatives from AOPA, the O&P Alliance, and the Amputee Coalition met with CMS Acting Administrator Andrew Slavitt as well as other high ranking CMS and HHS officials to reiterate the concerns of the O&P community regarding the potential impact of the draft LCD and Policy Article. Reports from this meeting indicate that it was extremely positive and that CMS will be discussing the draft LCD and Policy Article further with its DME MAC contractors.
On August 11, AOPA, along with other industry leaders, met with the Deputy Director of CMS, Sean Cavanaugh, to discuss the DME MAC’s draft LCD Lower Extremity Prosthetics and Policy Article. We challenged the dearth of scientific support for the policy and reiterated the O&P Alliance request for rescission of the policy. We pledged to work in earnest with CMS, the DME MACs and other stakeholders, starting with a demonstration project through the CMS Center for Innovation that would update coding, be both evidence-based and value-based, and benefit patients—all of the things that this draft proposal is not.
Data Analysis & FOIA Request/ Researchers Weigh In
AOPA invested time and money to capture the current state of Medicare payments for prosthetics. Data analysis shows that Medicare prosthetic costs are DOWN 13.8% in past 4 years. The 2005-2010 data used by CMS contractors to support their proposed policy was based on outdated information.
AOPA submitted a Freedom of Information Act Request to determine the scientific basis for the proposed policy. The response from the DME MACs included a 31 item bibliography which is woefully weak in providing any scientific evidence to support the proposed changes. Some of the authors cited in the bibliography acknowledged their work cited by the DME MACs does not provide any support for proposed changes.
In a jointly signed letter to the DME MACs the researchers said: “The current standard of practice is fully supported by sound, (peer-reviewed) scientific evidence. The changes proposed are not consistent with the current standard of practice and not derived from consultation with any of the referenced authors. As CMS has used our works in the preparation of this ill-conceived proposal, we are led to question why we, as health care experts in this field, were not consulted. The proposed changes … in our expert opinion, would diminish both the quality and access to prosthetic care across our nation. We, as the experts cited in this document, wish to go on record as strongly opposing the draft [rule].”
Medical Experts Sign On
AOPA sought collaboration which resulted in a group letter from three past presidents of the American Academy of Orthopedic Surgeons, physicians from the University of Iowa, plus communications from a President of the Association of Bone & Joint Surgeons, the American Orthopaedic Foot and Ankle Society, and the International Federation of Foot and Ankle Societies—all opposing the proposed policy changes.
Legislators Weigh In
AOPA has communicated with legislators about the harmful draft proposal, resulting in letters to Secretary Burwell from Senators and Representatives from both sides of the aisle:
Rep. Brett Guthrie (R-KY-2)
Rep. Renee Ellmers (R-NC-2)
Rep. Erik Paulsen (R-MN-3) and Rep. Anna Eshoo (D-CA-18)
Rep. Tammy Duckworth (D-IL)
Sen. Amy Klobuchar (D-MN) and Sen. Dan Coats (R-IN)
Rep. Kay Granger (R-TX-12)
Rep. Joe Heck (R-NV-3)
and five House Representatives from Indiana
The VA Weighs In
Read the comments submitted by the VA to the Medical Directors.
Mobility Saves Communicates with Stakeholders
AOPA’s www.mobilitysaves.org is a resource for practitioners, other caregivers, insurance professionals and consumers for communicating how timely appropriate O&P care reduces long-term costs. Valuable information such as patient vignettes, the PR campaign, and amputee talking points were posted to communicate information on this specific proposed policy. Also featured is a remarkable letter authored by amputee and former U.S. Senator Bob Kerrey explaining to HHS Secretary Burwell how detrimental implementation of this policy would be for himself and other amputees.
Advertising Campaign Reaches the Public
AOPA developed print and television advertising campaigns using the concept of “The Prosthetic Glass Ceiling” to illustrate how an amputee patients can “see” new, improved prosthetic limbs, and advanced technologies that improve mobility, independence and quality of life, but are often denied these new enhanced prosthetic limbs. The print message ran in The Washington Post and The Hill, and the video ran on This Week with George Stephanopoulos and several other Sunday news programs in Washington, DC.
Members can visit MobilitySaves.org to access the AOPA TV/broadcast “Glass Ceiling” message and post it on social media. You can spread the word by providing a link to the Mobility Saves page where both of these messages are displayed.
Public Relations—Patient Vignettes, 350 News Stories—Teleconference
AOPA generated a series of Patient Vignettes in cooperation with the Amputee Coalition that communicate the personal impact of the proposed LCD on patient care, eligibility for advanced prosthetics and overall patient welfare.
A joint AOPA/Amputee Coalition teleconference Press Conference was held August 25 to alert the media about the August 26th hearing and patient rally at HHS.
Over 350 news stories about how amputees and prosthetic businesses could be impacted by this policy have been generated by all of these efforts.
A “We the People” petition to the White House was started by NAAOP President (and AOPA Board Member) Dave McGill which achieved its 100,000+ signatures mark in just 17 days. The White House promises response to any petition which includes 100,000 signatures.
But what has happened since the closing of the comments on August 31st?
AOPA Met with Office of Management & Budget
On September 16, AOPA Executive Director Tom Fise, along with our health care council, met with 7 representatives from the Office of Management & Budget (OMB) relating to the CMS Final Rule on Prior Authorization (you’ll recall the comment period closed about a year ago) which must be approved by OMB before it can be published. During the meetings with CMS on August 26 relating to the LCD, AOPA secured a promise from CMS’ Chief Medical Officer to look closely at the Prior Authorization rule, as we contended that the combined effects of moving on both the LCD and Prior Authorization would have an exponential adverse impact on amputee patient care.
Getting OMB to intervene is a high bar to surmount, but AOPA had a positive exchange with them. Overall our central message addressed three key points: (1) the Prior Authorization regulation was a CMS attempt to solve a problem which does not exist–no such extraordinary steps are needed to control Medicare expenditures for prosthetics because data shows that contrary to the OIG report, those expenditures have gone down in each of the past three years, and 2013 expenditures were less that expenditures in 2007; (2) the rule would prompt a decline in quality of care; and (3) it would delay patient receipt of care. The discussion included AOPA’s assertion that the rule should NOT be enacted, but adding that if it was to be enacted, five criteria outlined in AOPA’s comments (including that it needs to be a guarantee of payment, that it needs to establish that there would be no medical necessity audits once Prior Authorization was secured, and that the prosthetist notes prohibition must be fixed). We cited materials from the LCD press and amputee demonstration, including Senator Kerrey’s characterization that the LCD (and by analogy the Prior Authorization) was an instance of the government ‘creating a problem, not solving one.’
We will be providing some follow-up materials in areas of questions. We will get no response (as they are not allowed to hint at the Final Policy), other than what we can observe in whether the rule moves forward into publication, and what provisions it contains.
Wall Street Journal Article Published
After the initial media buzz of more than 350 press articles on the HHS rally and LCD Proposal, the media is still picking up on the issue in a big way: On September 20, The Wall Street Journal published an article on the issue.
Senators Dan Coats and Amy Klobuchar
Senators Coats (R-IN) and Klobuchar (D-MN), co-chairs of the Senate Medical Technology Caucus communicated with CMS Acting Administrator Andy Slavitt, urging CMS to immediately reconsider the policy proposal. Other legislators have weighed in with letters to HHS Secretary Sylvia Burwell and to CMS Administrator Slavitt; read those letters here.